CD9 and esophageal squamous cell carcinoma: The expression of CD9 is associated with ESCC staging and lymph node metastasis, and the expression of CD9 in metastatic ESCC tissues is significantly higher than that in non-metastatic tissues, indicating that CD9 is a characteristic of malignant progression (15).